Topics
Innovation
Laser
Medical
Practice
Research
Surgical
Training
An update on the clinical development of a new class of drugs.
Jason Bacharach, MD
These therapies have the potential to change the glaucoma treatment paradigm.
Jonathan S. Myers, MD, and Scott J. Fudemberg, MD
Try one or all of these tips to help patients understand their treatment plan.
Fiaz Zaman, MD
The contribution of systemic medication to dry eye disease.
Sejal R. Amin, MD, and Christopher T. Hood, MD
Generic medications offer therapeutic benefits for some patients.
Marcos Reyes, MD, and Lauren Wiggins, MD
There is plenty of interest but relatively few drugs in advanced-stage development.
Gary D. Novack, PhD
In-office technologies aid clinicians' diagnosis and treatment of DED.
Howard Barnebey, MD
Research suggests that many issues other than IOP may play a role in the pathophysiology of glaucoma.
Shan Lin, MD
Treatments for some mental illnesses can cause or exacerbate glaucoma.
Julia Song, MD
Three surgeons discuss the clinical scenarios in which they prescribe these drugs.
L. Jay Katz, MD; Robert J. Noecker, MD, MBA; and James C. Tsai, MD, MBA
The future is awesome.
F. Fallon Ukpe, MD, MBA, and Jai G. Parekh, MD, MBA
Based on the results of preclinical studies, this neurotrophic factor is a candidate for clinical use.
Keiichiro Iwao, MD, PhD, and Jeffrey L. Goldberg, MD, PhD
Topical prostaglandins may be a viable nonsurgical option for Asian patients who desire a double eyelid crease.
Many patients' tolerability to medications can improve with aggressive treatment of ocular surface disease.
Steven T. Simmons, MD
Donor eyes provide key insights into the pathophysiology of primary open-angle glaucoma.
Abbot F. Clark, PhD
A common pathological mechanism explains the corneal, iris, and angle abnormalities that result in a rare but important type of secondary angle-closure glaucoma.
Matthew D. Lazzara, MD, and Angelo P. Tanna, MD
Minimize medications and dosing frequency to limit the risks to the mother, fetus, and breastfed infant.
Pradeep Y. Ramulu, MD, MHS, PhD, and Sarwat Salim, MD
A systematic approach to glaucoma adherence is needed.
Robert M. Kinast, MD, and Steven L. Mansberger, MD, MPH
Concepts in pharmacokinetics are applied in practical ways to the management of ocular infections. However, the selection of bacterial minimum inhibitory concentrations that are artificially low may skew certain parameters used to predict antibacterial efficacy.
SUSANNE GARDNER, PHARMD
Stay Up to Date
Stay up to date all on all things Aesthetics by sigining up to recieve our print publication or subscribe to our email alerts.
Advertisement
